These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25141949)

  • 1. Biotransformation.
    Ito S
    Clin Pharmacol Ther; 2014 Sep; 96(3):281-3. PubMed ID: 25141949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A question-based approach to adopting pharmacogenetics to understand risk for clinical variability in pharmacokinetics in early drug development.
    Evers R; Blanchard RL; Warner AW; Cutler D; Agrawal NG; Shaw PM
    Clin Pharmacol Ther; 2014 Sep; 96(3):291-5. PubMed ID: 25141952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual response to drug therapy: bases and study approaches.
    León-Cachón RB; Ascacio-Martínez JA; Barrera-Saldaña HA
    Rev Invest Clin; 2012; 64(4):364-76. PubMed ID: 23227587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetics: current state after 30 years of research].
    Eichelbaum M
    Dtsch Med Wochenschr; 2013 Mar; 138(13):659-61. PubMed ID: 23512369
    [No Abstract]   [Full Text] [Related]  

  • 5. Using genetic diagnosis to determine individual therapeutic utility.
    Caskey CT
    Annu Rev Med; 2010; 61():1-15. PubMed ID: 19824818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics of human uridine diphospho-glucuronosyltransferases and clinical implications.
    Guillemette C; Lévesque É; Rouleau M
    Clin Pharmacol Ther; 2014 Sep; 96(3):324-39. PubMed ID: 24922307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic tests give the finishing touch to individual drug dosage].
    Sjöqvist F
    Lakartidningen; 2003 Feb; 100(8):592-3. PubMed ID: 12640970
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacogenetics, race, and psychiatry: prospects and challenges.
    Jones DS; Perlis RH
    Harv Rev Psychiatry; 2006; 14(2):92-108. PubMed ID: 16603475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacogenetics--pathway to individualized antihypertensive pharmacotherapy].
    Kurland L; Lind L; Lithell H; Syvänen AC; Melhus H
    Lakartidningen; 2003 Feb; 100(8):600-3. PubMed ID: 12640971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confounding in genetic association studies and its solutions.
    Hu D; Ziv E
    Methods Mol Biol; 2008; 448():31-9. PubMed ID: 18370229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochromes P450: decision-making tools for personalized therapeutics.
    Murray M; Petrovic N
    Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel pharmacogenomics: next steps: a clinical algorithm, gene-gene interactions, and an elusive outcomes trial.
    Gladding P; Panattoni L; Webster M; Cho L; Ellis S
    JACC Cardiovasc Interv; 2010 Oct; 3(10):995-1000. PubMed ID: 20965455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylator status, drug metabolism and disease.
    Pande JN; Pande A; Singh SP
    Natl Med J India; 2003; 16(1):24-6. PubMed ID: 12715953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacogenetics and the hospital pharmacy].
    Aldaz A
    Farm Hosp; 2011; 35(4):163-4. PubMed ID: 21741871
    [No Abstract]   [Full Text] [Related]  

  • 15. The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery.
    Yan Q
    Methods Mol Biol; 2008; 448():1-19. PubMed ID: 18370227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of variability in antiplatelet agents response.
    Cattaneo M
    Thromb Res; 2012 Oct; 130 Suppl 1():S27-8. PubMed ID: 23026654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.
    Sleder AT; Kalus J; Lanfear DE
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):20-6. PubMed ID: 26054891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacogenetics I. Concept, history, objectives and areas of study].
    Daudén Tello E
    Actas Dermosifiliogr; 2006 Dec; 97(10):623-9. PubMed ID: 17173823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of osteoporosis: future perspectives.
    Marini F; Brandi ML
    Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacometabonomics, pharmacogenomics and personalized medicine.
    Guţiu IA; Andrieş A; Mircioiu C; Rădulescu F; Georgescu AM; Cioacă D
    Rom J Intern Med; 2010; 48(2):187-91. PubMed ID: 21428184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.